COL4A5 mutation causes Alport syndrome with focal segmental glomerulosclerosis lesion: Case report and literature review

Clin Nephrol. 2019 Aug;92(2):98-102. doi: 10.5414/CN109737.

Abstract

COL4A5 gene mutations are known as the cause of Alport syndrome (AS), which typically manifests with hematuria, progressive renal failure, sensorineural hearing loss, and ocular abnormalities. Here we report a case of a 20-year-old male patient presenting with nephrotic syndrome who was diagnosed as having AS with focal segmental glomerulosclerosis (FSGS) lesion after the renal biopsy was performed. In this patient, the link between AS and FSGS lesion is complicated. Whole-exome sequencing was performed to identify its causal genetic variants, and the results revealed that AS with FSGS lesion is caused by mutation of the COL4A5 gene. COL4A5 gene mutations have phenotypic heterogeneity and thus, we suggest that genetic testing should be considered in such patients for accurate diagnosis and appropriate treatment.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Collagen Type IV / genetics*
  • Genetic Testing
  • Glomerulosclerosis, Focal Segmental / genetics*
  • Glomerulosclerosis, Focal Segmental / pathology
  • Hematuria / etiology
  • Humans
  • Male
  • Mutation / genetics*
  • Nephritis, Hereditary / complications
  • Nephritis, Hereditary / genetics*
  • Nephritis, Hereditary / pathology
  • Young Adult

Substances

  • COL4A5 protein, human
  • Collagen Type IV